Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1139 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Ravulizumab for treating generalised myasthenia gravis	Ravulizumab (ALXN1210; Ultomiris)	Myasthenia gravis (MG)	Musculoskeletal System	2021	View \| Download
Ravulizumab for treating thrombotic microangiopathies following haematopoietic stem cell transplantation in children	Ravulizumab (ALXN1210; Ultomiris)	Thrombotic microangiopathies	Haematology	2023	View \| Download
Ravulizumab for treatment of neuromyelitis optica spectrum disorder	Ravulizumab (ALXN1210; Ultomiris)	Neuromyelitis optica spectrum disorders	Nephrology , Ophthalmology	2022	View \| Download
RBX-2660 for the Treatment of Recurrent Clostridium Difficile Infection – third line	RBX-2660	Clostridioides difficile infection	Infectious Disease	2018	View \| Download
Refanalin for Delayed Graft Function Following Kidney Transplant	Refanalin (BB-3; ANG-3777)	Delayed graft function (DGF)	Nephrology	2018	View \| Download
REGN5458 for relapsed or refractory multiple myeloma	REGN5458	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2022	View \| Download
Relatlimab in combination with nivolumab for advanced melanoma – second line	Nivolumab (Opdivo; BMS-936558; ONO-4538) , Relatlimab (BMS-986016; Anti-LAG-3)	Melanoma	Skin Cancer	2019	View \| Download
Relugolix combination therapy for treating endometriosis-associated pain	Relugolix (TAK-385)	Endometriosis-associated pain	Gynaecology and Obstetrics , Pain Relief	2021	View \| Download
Relugolix for treating advanced hormone-sensitive prostate cancer	Relugolix (TAK-385)	Prostate cancer	Male Reproductive Cancer	2022	View \| Download
Relugolix in combination with estradiol/norethindrone acetate for moderate to severe symtpoms of uterine fibroids	Relugolix (TAK-385)	Heavy menstrual bleeding	Gynaecology and Obstetrics	2020	View \| Download